Examples of 'mucoadhesive' in a sentence
Meaning of "mucoadhesive"
mucoadhesive (adjective): Refers to substances or products that have the ability to adhere to mucus membranes in the body
Show more definitions
- That adheres to a mucous membrane.
- Any drug that adheres to a mucous membrane
How to use "mucoadhesive" in a sentence
Basic
Advanced
mucoadhesive
Bioadhesive and mucoadhesive can be used interchangeably.
It does not teach colloidal clay as a mucoadhesive aid.
Mucoadhesive formulation containing strontium ibuprofen.
Also described herein is a mucoadhesive agent which is a cellulose.
Mucoadhesive hydrogel comprising ibuprofen and strontium chloride.
Also described herein is a mucoadhesive agent which is a carbopol.
Mucoadhesive properties are desirable for buccal delivery systems.
Chitosans are cationic polymers that have mucoadhesive properties.
Mucoadhesive compositions are also useful.
A higher nb means greater mucoadhesive properties.
Mucoadhesive compositions are particularly useful.
According to the invention a mucoprotective agent is a mucoadhesive alone.
Mucoadhesive polymers are typically polymers having hydrogen bonding groups.
Suitably the source of the drug is a mucoadhesive preparation.
Mucoadhesive granules comprising a blend of.
See also
These films may also have mucoadhesive properties.
Mucoadhesive buccal tablets are recovered.
A variety of polymers was as potential mucoadhesive vehicles.
Mucoadhesive agents as used in the invention may be natural or synthetic.
In some cases a low viscosity mucoadhesive may provide effective treatment.
The mucoadhesive buccal patches of analgesics have been investigated inclusive of tramadol.
Buffering agents are included in the mucoadhesive mucoadhesive polymeric diffusion environment.
Mucoadhesive pharmaceutical composition for the controlled release of active principles.
Several bioadhesive polymers are available with varying degree of mucoadhesive performance.
Suitable mucoadhesive polymers useful in the present invention exhibit pH responsiveness.
The compositions of the present invention also contain a mucoadhesive polymer.
Both mucoadhesive surfaces are formulated for the transmucosal delivery of buprenorphine.
Thiolation of polymers has been disclosed to further increase their mucoadhesive properties.
Mucoadhesive materials in the form of polymers are normally capable of forming hydrogels.
In this embodiment the delivery vehicle preferably comprises a mucoadhesive substance.
The mucoadhesive strength of the patches was determined by placing patches on porcine intestine.
The pharmaceutical compositions of the invention may include mucoadhesive polymers.
The mucoadhesive agent used in any composition described herein comprises a maltodextrin.
Such an interaction can confer beneficial mucoadhesive properties to the vehicle.
Mucoadhesive derivatives include chemically modified agents which retain mucoadhesive properties.
Neutral liposomes may be prepared from phosphatidylcholine associated with mucoadhesive polymers.
Other mucoadhesive bioerodable polymers may also be used in the present invention.
In one alternative embodiment there is no envelope material with mucoadhesive properties present.
And for the same buccal mucoadhesive patches are considered to be the best approach.
In certain embodiments the antagonist is encapsulated within at least one mucoadhesive layer.
Said prolonged release mucoadhesive buccal tablets have many advantages as described below.
On administration the tablets disintegrate in the stomach contents to release mucoadhesive granules.
In some previous studies also the mucoadhesive dosage forms have been developed for tramadol.
The dry pharmaceutical compositions may further comprise one or more mucoadhesive agents.
Solid mucoadhesive therapeutic or hygienic composition for application to the buccal or nasal mucous membrane.
Further dilution will decrease or eliminate the mucoadhesive property of the present compositions.
The mucoadhesive process will differ greatly depending on the surface and properties of the adhesive.
The document describes particles comprising a therapeutic agent and a mucoadhesive in a mixed state.
Virtually all of the prior art mucoadhesive systems require polymers to provide the mucoadhesive benefit.
Such incompatibilities can prevent entire classes of active agents being incorporated within the mucoadhesive device.
